Clinical Scorecard: Glaucoma: Embracing Interventional Management
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma |
| Key Mechanisms | Elevated intraocular pressure (IOP) causing optic nerve damage; impaired aqueous outflow through trabecular meshwork |
| Target Population | Patients diagnosed with glaucoma requiring IOP control |
| Care Setting | Primary eye care and specialized glaucoma clinics |
Key Highlights
- Traditional glaucoma management is reactive, relying heavily on patient adherence to topical medications before considering surgical interventions.
- Interventional glaucoma (IG) management emphasizes early diagnostic use, advanced monitoring, and proactive laser and surgical interventions.
- IG strategies reduce dependence on daily medication adherence, improving long-term visual stability and patient quality of life.
Guideline-Based Recommendations
Diagnosis
- Utilize early diagnostic devices to detect glaucoma and monitor progression proactively.
Management
- Incorporate selective laser trabeculoplasty (SLT) early to improve aqueous outflow and reduce medication burden.
- Consider minimally invasive glaucoma surgery (MIGS) during cataract surgery or as a standalone procedure for enhanced IOP control.
- Use sustained-release drug delivery platforms to provide long-term medication delivery and reduce reliance on daily drops.
- Employ anti-glaucoma medications as bridge therapies to interventional treatments.
Monitoring & Follow-up
- Implement advanced monitoring techniques to track disease progression and treatment efficacy.
Risks
- Non-adherence to topical medications can lead to disease progression and vision loss.
- Delaying interventional treatments may compromise long-term visual outcomes.
Patient & Prescribing Data
Glaucoma patients with challenges in medication adherence
Interventional approaches such as SLT, MIGS, and sustained-release drug delivery reduce dependence on patient compliance and improve IOP control.
Clinical Best Practices
- Adopt a proactive interventional glaucoma management model early in the disease course.
- Educate patients on the benefits of early laser and surgical interventions to improve adherence and outcomes.
- Integrate advanced diagnostic and monitoring tools to guide timely treatment decisions.
- Use anti-glaucoma medications as temporary measures while planning definitive interventional therapies.
References
- Selective Laser Trabeculoplasty (SLT) Mechanism
- Achieving patient adherence to IOP-lowering drugs by Dr. Justin Holt
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


